Senior Business Analyst at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Strong commitment to a career in technology with a passion for healthcare and impact on patients
Proven experience with ELN/LIMS in biotech/pharma research labs
Degree in Biological or Chemical Sciences with prior hands-on research experience
Knowledge of molecular biology, antibody discovery, protein chemistry/biochemistry workflows and data management
Comfort translating scientific needs into system configurations, integrations, and training
Ability to work collaboratively with scientists, IT colleagues, vendors, and contractors
Demonstrated success operating within a matrixed organization and driving consensus
Strong focus on user experience, change management, and adoption
Excellent communication skills and agility to learn new tools and processes

Responsibilities

Requirements Gathering: Collaborate with scientists and lab managers to understand experimental workflows; document user needs, process maps, and data standards for ELN/LIMS and GenAI use cases
Solution Design: Partner with platform engineers and vendors to design configurations (schemas, registration models, templates, routing), integrations (APIs/webhooks/ETL), roles/permissions, and audit/traceability aligned with BMS standards
GenAI Enablement: Identify high-value GenAI opportunities (e.g., protocol drafting, experiment summarization, semantic search, assay troubleshooting assistants); define guardrails, evaluation, and privacy controls; support pilots through scale-up
Instrument & Data Connectivity: Coordinate instrument data capture, ensure metadata/FAIR practices, and support interoperability with analytics/warehouse environments
Delivery & Support: Manage backlogs and Jira boards; write user stories and acceptance criteria; plan and script UAT; develop training materials and conduct structured end-user training; provide post-go-live support
Compliance & Quality: Partner with QA/Validation as applicable (e.g., 21 CFR Part 11, GxP/CLIA contexts), ensuring documentation

Skills

LIMS

ELN

Generative AI

GenAI

Instrument Connectivity

Requirements Gathering

Workflow Design

Data Quality

Compliance

Business Analysis

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free